Literature DB >> 18258940

Aspirin resistance: What is the risk of cardiovascular morbidity?

Peter Elwood, Gareth Morgan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18258940      PMCID: PMC2234558          DOI: 10.1136/bmj.39479.465706.3A

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  5 in total

1.  Adherence to aspirin in the prevention of myocardial infarction. The Physicians' Health Study.

Authors:  R J Glynn; J E Buring; J E Manson; F LaMotte; C H Hennekens
Journal:  Arch Intern Med       Date:  1994 Dec 12-26

2.  Compliance as a critical consideration in patients who appear to be resistant to aspirin after healing of myocardial infarction.

Authors:  Kenneth A Schwartz; Dianne E Schwartz; Khalid Ghosheh; Mathew J Reeves; Kimberly Barber; Anthony DeFranco
Journal:  Am J Cardiol       Date:  2005-04-15       Impact factor: 2.778

3.  Platelet tests in the prediction of myocardial infarction and ischaemic stroke: evidence from the Caerphilly Prospective Study.

Authors:  P C Elwood; A Beswick; J Pickering; P McCarron; J R O'Brien; S R Renaud; R J Flower
Journal:  Br J Haematol       Date:  2001-05       Impact factor: 6.998

Review 4.  Aspirin "resistance" and risk of cardiovascular morbidity: systematic review and meta-analysis.

Authors:  George Krasopoulos; Stephanie J Brister; W Scott Beattie; Michael R Buchanan
Journal:  BMJ       Date:  2008-01-17

5.  Bleeding time, stroke and myocardial infarction: the Caerphilly prospective study.

Authors:  P C Elwood; Janet Pickering; J Yarnell; J R O'Brien; Y Ben Shlomo; P Bath
Journal:  Platelets       Date:  2003-05       Impact factor: 3.862

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.